[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349085-105":59,"doc-detail-349085-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","en2-regulates-pancreatic-cancer-initiation-progression-and-epithelial-mesenchymal-transition-through-the-notch-signalling-pathway-original-article-open-access","EN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial-Mesenchymal Transition Through the Notch Signalling Pathway - Original Article - Open Access","","Pancreatic cancer incidence and mortality are rising worldwide, with the disease projected to become a leading cause of cancer-related deaths by 2030. Pancreatic tumorigenesis involves multiple genetic alterations, requiring clearer molecular mechanisms. This study identifies Engrailed 2 (EN2) as a novel oncogenic driver of pancreatic cancer initiation and progression. EN2 is elevated in tumor tissues and pancreatic cancer cell lines, linked to poor survival in TCGA, and it regulates targets in pluripotency, survival, cell-cycle control, drug resistance, and epithelial–mesenchymal transition. EN2 knockdown reduces proliferation, invasion, metastasis, and xenograft tumor growth partly via Notch signalling inhibition.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/en2-regulates-pancreatic-cancer-initiation-progression-and-epithelial-mesenchymal-transition-through-the-notch-signalling-pathway-original-article-open-access/349085/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/en2-regulates-pancreatic-cancer-initiation-progression-and-epithelial-mesenchymal-transition-through-the-notch-signalling-pathway-original-article-open-access/349085.png","ImageObject",300,407,{"name":92,"@type":93},"นรินทร์","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does EN2 play in pancreatic cancer initiation and progression?","Question",{"text":112,"@type":113},"EN2 acts as an oncogenic driver that regulates key genes involved in pluripotency, survival, cell-cycle progression, drug resistance, and epithelial–mesenchymal transition, supporting initiation and progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was EN2 expression evaluated in the study?",{"text":117,"@type":113},"EN2 expression was assessed using immunohistochemical analysis on a pancreatic cancer tissue microarray, gene/protein upregulation in human pancreatic cancer cell lines, and corroboration with TCGA data.",{"name":119,"@type":110,"acceptedAnswer":120},"What was the effect of reducing EN2 in pancreatic cancer models?",{"text":121,"@type":113},"Lentiviral shRNA knockdown of EN2 suppressed pancreatic cancer cell proliferation, invasion, and metastasis in vitro and significantly inhibited tumor growth in a xenograft mouse model.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349085,1791161434,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336475104957,"https://ap-avatar.wpscdn.com/avatar/22000c4c6bd8a5076e1?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787554080175789136","Journal of Cellular and Molecular Medicine   \n ORIGINAL ARTICLE  OPEN ACCESS   \nEN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial-Mesenchymal Transition Through the Notch Signalling Pathway  \nWei Yu1 | Raj K. Varma1 | Yiming Ma1 | Varun Chandra Boinpelly1 | Areej Khatri2 | Emma Gombos2 | Rakesh K. Srivastava1  | Sharmila Shankar1,3,4   \n1Kansas City VA Medical Center, Kansas City, Missouri, USA | 2Department of Cell and Molecular Biology, Tulane University, New Orleans, Louisiana, USA | 3John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA | 4Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA  \nCorrespondence: Sharmila Shankar ([sharmilashankar2@gmail.com](sharmilashankar2@gmail.com))  \nReceived: 27 March 2026 | Revised: 27 March 2026 | Accepted: 7 April 2026  \nKeywords: Bcl-2 | cMyc | cyclin D1 | EN2 | Nanog | notch | Oct4 | pancreatic cancer | transformation  \nABSTRACT  \nThe incidence and mortality of pancreatic cancer are steadily increasing worldwide, and the disease is projected to become the second leading cause of cancer-related deaths by 2030. Pancreatic tumorigenesis is driven by multiple genetic alterations, underscoring the need to elucidate the molecular mechanisms underlying pancreatic carcinogenesis. In this context, the present study is the first to identify a novel oncogenic role for Engrailed 2 (EN2) in the initiation and progression of pancreatic cancer and to characterise its underlying molecular pathogenesis. Immunohistochemical analysis of a pancreatic cancer tissue microarray revealed significantly elevated EN2 expression in tumour tissues compared with adjacent normal tissues. Consistent with these findings, EN2 was markedly upregulated in human pancreatic cancer cell lines, but absent in normal pancreatic epithelial cells, and functional studies demonstrated that EN2 expression is oncogenic in pancreatic cancer. TCGA data further corroborated the significantly higher EN2 expression in pancreatic cancer tissues and showed that elevated EN2 levels are associated with poor overall survival. To define the biological significance of EN2, we investigated its role in promoting pancreatic cancer initiation and progression. Gain-and loss-of-function studies revealed that EN2 regulates key target genes involved in pluripotency, cell survival, and cell-cycle progression, drug resistance, and epithelial–mesenchymal transition. Moreover, lentiviral-mediated shRNA knockdown of EN2 suppressed pancreatic cancer cell proliferation, invasion, and metastasis in vitro and significantly inhibited tumour growth in a xenograft mouse model, in part by inhibiting Notch signalling. Taken together, these findings identify EN2 as a critical driver of pancreatic cancer initiation, progression, and metastasis, representing the first report of its oncogenic function in this malignancy.  \n1 | Introduction  \nPancreatic ductal adenocarcinoma (PDAC), the predominant histological subtype, is currently the third leading cause of cancer-related mortality in the United States. The incidence and mortality of pancreatic cancer continue to rise [1] . In 2025, an estimated 67,440 new cases were diagnosed in the  \nUnited States, and approximately 51,980 individuals died from the disease [2]. The incidence and mortality of pancreatic cancer continue to rise, reflecting both an ageing population and the growing prevalence of risk factors such as obesity, diabetes, and chronic pancreatitis. Despite incremental therapeutic advances, PDAC remains one of the most lethal malignancies, largely because most patients present with advanced,  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Me","cbCaiareDBxYEiKo","https://ap.wps.com/l/cbCaiareDBxYEiKo","pdf",10058808,13,"English","# Introduction\n## Background on pancreatic ductal adenocarcinoma and mortality trends\n## Role of EN2 and HOX gene family in cancer and stem-cell self-renewal\n## Rationale for investigating EN2 in PDAC and potential biomarker value","[{\"question\":\"What role does EN2 play in pancreatic cancer initiation and progression?\",\"answer\":\"EN2 acts as an oncogenic driver that regulates key genes involved in pluripotency, survival, cell-cycle progression, drug resistance, and epithelial–mesenchymal transition, supporting initiation and progression.\"},{\"question\":\"How was EN2 expression evaluated in the study?\",\"answer\":\"EN2 expression was assessed using immunohistochemical analysis on a pancreatic cancer tissue microarray, gene/protein upregulation in human pancreatic cancer cell lines, and corroboration with TCGA data.\"},{\"question\":\"What was the effect of reducing EN2 in pancreatic cancer models?\",\"answer\":\"Lentiviral shRNA knockdown of EN2 suppressed pancreatic cancer cell proliferation, invasion, and metastasis in vitro and significantly inhibited tumor growth in a xenograft mouse model.\"}]","EN2 Regulates Pancreatic Cancer Initiation, Progression, and Epithelial-Mesenchymal Transition Through the Notch Signalling Pathway - Original Article - Open Access | PDF",1790081553,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c54e8acc709f94f7f1b87cc8ade68d81.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84d47269847fe319321434f5d596e970.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/560c2759ff52c112baf4d7b7ef5702af.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2a9381aeb1ef317212936657eddbf77.webp",980,1287]